BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 34163158)

  • 1. Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome-Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes.
    Petrini M; Lokerse WJM; Mach A; Hossann M; Merkel OM; Lindner LH
    Int J Nanomedicine; 2021; 16():4045-4061. PubMed ID: 34163158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
    Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
    J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DPPG
    van Valenberg FJP; Brummelhuis ISG; Lindner LH; Kuhnle F; Wedmann B; Schweizer P; Hossann M; Witjes JA; Oosterwijk E
    Int J Nanomedicine; 2021; 16():75-88. PubMed ID: 33447028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, Tissue Distribution and Therapeutic Effect of Cationic Thermosensitive Liposomal Doxorubicin Upon Mild Hyperthermia.
    Dicheva BM; Seynhaeve AL; Soulie T; Eggermont AM; Ten Hagen TL; Koning GA
    Pharm Res; 2016 Mar; 33(3):627-38. PubMed ID: 26518763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted and heat-triggered doxorubicin delivery to tumors by dual targeted cationic thermosensitive liposomes.
    Dicheva BM; ten Hagen TL; Schipper D; Seynhaeve AL; van Rhoon GC; Eggermont AM; Koning GA
    J Control Release; 2014 Dec; 195():37-48. PubMed ID: 25176578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic investigation of thermosensitive liposome immunogenicity and understanding the drivers for circulation half-life: A polyethylene glycol versus 1,2-dipalmitoyl-sn-glycero-3-phosphodiglycerol study.
    Lokerse WJM; Lazarian A; Kleinhempel A; Petrini M; Schwarz P; Hossann M; Holdt LM; Mailänder V; Lindner LH
    J Control Release; 2021 May; 333():1-15. PubMed ID: 33741385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DPPG
    Brummelhuis ISG; Simons M; Lindner LH; Kort S; de Jong S; Hossann M; Witjes JA; Oosterwijk E
    Int J Hyperthermia; 2021; 38(1):1415-1424. PubMed ID: 34581259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors.
    Peller M; Willerding L; Limmer S; Hossann M; Dietrich O; Ingrisch M; Sroka R; Lindner LH
    J Control Release; 2016 Sep; 237():138-46. PubMed ID: 27364227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
    Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
    J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel two-step mild hyperthermia for advanced liposomal chemotherapy.
    Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA
    J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes.
    Dicheva BM; ten Hagen TL; Seynhaeve AL; Amin M; Eggermont AM; Koning GA
    Pharm Res; 2015 Dec; 32(12):3862-76. PubMed ID: 26202516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of release and pharmacokinetics of hexadecylphosphocholine (miltefosine) in phosphatidyldiglycerol-based thermosensitive liposomes.
    Rysin A; Paal M; Lokerse WJM; Wedmann B; Hossann M; Vogeser M; Winter G; Lindner LH
    Biochim Biophys Acta Biomembr; 2021 Nov; 1863(11):183698. PubMed ID: 34283999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine treatment of rat soft tissue sarcoma with phosphatidyldiglycerol-based thermosensitive liposomes.
    Limmer S; Hahn J; Schmidt R; Wachholz K; Zengerle A; Lechner K; Eibl H; Issels RD; Hossann M; Lindner LH
    Pharm Res; 2014 Sep; 31(9):2276-86. PubMed ID: 24599802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
    Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM
    J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermal combination therapies for local drug delivery by magnetic resonance-guided high-intensity focused ultrasound.
    Hijnen N; Kneepkens E; de Smet M; Langereis S; Heijman E; Grüll H
    Proc Natl Acad Sci U S A; 2017 Jun; 114(24):E4802-E4811. PubMed ID: 28566498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface-modified cationic liposomes with a matrix metalloproteinase-degradable polyethylene glycol derivative improved doxorubicin delivery in murine colon cancer.
    Askarizadeh A; Mashreghi M; Mirhadi E; Mehrabian A; Heravi Shargh V; Badiee A; Alavizadeh SH; Arabi L; Kamali H; Jaafari MR
    J Liposome Res; 2024 Jun; 34(2):221-238. PubMed ID: 37647288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
    Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
    Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermosensitive liposomes with higher phase transition temperature for targeted drug delivery to tumor.
    Chen J; He CQ; Lin AH; Gu W; Chen ZP; Li W; Cai BC
    Int J Pharm; 2014 Nov; 475(1-2):408-15. PubMed ID: 25218394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of Particle Accumulation, Chemosensitivity and Thermosensitivity for Effective Solid Tumor Therapy Using Thermosensitive Liposomes and Hyperthermia.
    Lokerse WJ; Bolkestein M; Ten Hagen TL; de Jong M; Eggermont AM; Grüll H; Koning GA
    Theranostics; 2016; 6(10):1717-31. PubMed ID: 27446503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes.
    Hossann M; Syunyaeva Z; Schmidt R; Zengerle A; Eibl H; Issels RD; Lindner LH
    J Control Release; 2012 Sep; 162(2):400-6. PubMed ID: 22759980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.